On Aug. 31, 2020, AstraZeneca announced that the COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial…
On Aug. 31, 2020, an international team of scientists supported by the National Institutes of Health (NIH) announced…
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
On Aug. 27, 2020, RedHill Biopharma announced that its U.S. Phase 2 study with opaganib (Yeliva®, ABC294640) in…
On Aug. 27, 2020, Vaccitech announced that it had received a non-dilutive Government grant to support research with…
On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…
On Aug. 27, 2020, Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19 from our CLIA-certified laboratory….
On Aug. 27, 2020, Assembly Biosciences and Arbutus Biopharma announced that the companies have entered into a clinical…
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with…
On Aug. 25, 2020, CytoDyn announced the Company had reached the requisite number of enrolled patients in its…
On Aug. 24, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
On Aug. 24, 2020, AXIM Biotechnologies announced that it had signed an exclusive limited licensing, manufacturing and distribution…
On Aug. 23, 2020, the Mayo Clinic announced that with the FDA Emergency Use Authorization of convalescent plasma,…
On Aug. 20, 2020, Sorrento Therapeutics and SmartPharm Therapeutics announced the signing of a merger agreement under which…
On Aug. 19, 2020, the National Institutes of Health (NIH) began requiring a small nonprofit research organization to…
On Aug. 19, 2020, Sorrento announced that it had filed an investigational new drug application (IND) for COVI-GUARD…
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofiaï¾® SARS…
On Aug. 19, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…
On Aug. 18, 2020, scientists from the Max Planck Institute for Biophysics, the Paul Ehrlich Institute, the European…
On Aug. 17, 2020, Atossa Therapeutics announced that it had enrolled and dosed the first cohort of healthy…
On Aug. 17, 2020, Scientisfic American reported that Costa Rican scientists at the Clodomiro Picado Institute have inoculated…
On Aug. 17, 2020, the USDA National Veterinary Services Laboratories (NVSL) announced the first confirmed cases of SARS-CoV-2…
On Aug. 17, 2020, PerkinElmer announced the launch of a series of explorerï¾™ workstations for SARS-CoV-2 testing capable…
On Aug. 17, 2020, Sanofi and Principia Biopharma announced a definitive agreement under which Sanofi will acquire all…
On Aug. 14, 2020, research supported by the National Institutes of Health delineated how two relatively common variations…
On Aug. 14, 2020, Medigen Vaccine Biologics (MBV) published preclinical results of their COVID-19 vaccine candidate in BioRxiv,…
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…